Larvol Delta - A-Study-of-Chidamide-Combined-With-Ivonescimab-in-the-Treatment-of-Advanced-NonSmall-Cell-Lung-Cancer-NSCLC-With-Acquired-Resistance-to-Immunotherapy-and-High-Yesassociated-Protein-YAP-Expression

Epidaza (chidamide) - Chipscreen

Idafang (ivonescimab) - Summit Therapeutics

http://clinicaltrials.gov/ct2/show/NCT07412262

Aug 26, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next